ArticleslgStudy

chemistry

Zilucoplan

Zilucoplan is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Zilucoplan rather than just read about it. In short: Zilucoplan, sold under the brand name Zilbrysq, is a medication used for the treatment of generalized myasthenia gravis. It is a complement inhibitor that is injected subcutaneously (under the skin).

Zilucoplan — main illustration
Zilucoplan — illustration

Key takeaways

  • Zilucoplan belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Zilucoplan to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Zilucoplan from memory before moving on to harder problems.

Reference excerpt

Zilucoplan, sold under the brand name Zilbrysq, is a medication used for the treatment of generalized myasthenia gravis. It is a complement inhibitor that is injected subcutaneously (under the skin). Zilucoplan is a cyclic peptide that binds to the protein complement component 5 (C5) and inhibits its cleavage into C5a and C5b. Zilucoplan was approved for medical use in the United States in October 2023, in the European Union in December 2023, and in Australia in July 2024.

Medical uses Zilucoplan is indicated for the treatment of generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positive.

Society and culture

Legal status In September 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Zilbrysq, intended for the treatment of myasthenia gravis. The applicant for this medicinal product is UCB Pharma S.A. Zilucoplan was approved for medical use in the Europea Union in December 2023. Zilucoplan was granted orphan drug designation by the US Food and Drug Administration (FDA) in August 2019, and by the EMA in July 2022.

Brand names Zilucoplan is the international nonproprietary name. Zilucoplan is sold under the brand name Zilbrysq.

References

External links Clinical trial number NCT04115293 for "Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE)" at ClinicalTrials.gov

Illustrations

Zilucoplan illustration

Worked examples

Example 1 — a first encounter with Zilucoplan

Start with the simplest possible case. Write down what Zilucoplan claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Zilucoplan before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Zilucoplan ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Zilucoplan

In research
Zilucoplan appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Zilucoplan in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Zilucoplan is common in secondary-school and first-year university syllabi. It links to neighbouring topics Amino acid derivatives, Complement system, Cyclic peptides, so understanding it makes those chapters shorter.
In everyday life
Look for Zilucoplan outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Zilucoplan” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Zilucoplan in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Zilucoplan means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Zilucoplan out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Zilucoplan in simple terms?

Zilucoplan, sold under the brand name Zilbrysq, is a medication used for the treatment of generalized myasthenia gravis. It is a complement inhibitor that is injected subcutaneously (under the skin).

Why does Zilucoplan matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Zilucoplan?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Zilucoplan.

Tags

  • Amino acid derivatives
  • Complement system
  • Cyclic peptides
  • Immunosuppressants
  • Orphan drugs

Keep exploring